Sphere Bio

Biologics & Biosimilars · Cell & Gene Therapy

Overview

We find, analyze and isolate the most valuable cells with ease and speed. Sphere Bio | Cell Selection, Sorted.

Funding and backers

Backers
1
Parkwalk Advisors
Momentum
0/100
no fresh signals
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Umoja BiopharmaVenture round $210M · 5 yr ago · Founded 2019 · 4 roles
Umoja Biopharma pioneering immunotherapy by reprogramming T cells in vivo to target cancer cells and generate lasting remission.
Biolinco201-500 employees
High-throughput cell line development for biopharmaceuticals. DNA barcoding platform that screens thousands of CHO cell lines…
Cell MicrosystemsVenture round $6.5M · 3 yr ago · Founded 2021 · 51-200 employees
Cell Microsystems develops innovative tools that allow researchers to image, sort, and isolate single cells and colonies for use in the…
Barinthus Biotherapeutic induces T cells and antibodies to treat and prevent disease.
LEAH LabsFounded 2018 · 11-50 employees
Designer cell therapies for pets first and their people next.
MediSix Therapeutics develops innovative T-cell therapies using its proprietary PEBL technology platform. An IASO Biotechnology subsidiary.

Connections

List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors1
151 portfolio companies: Zetta Genomics, Zentraxa Seed, Zomp and 148 more